Biological Nanoparticles for Enhancing Chronic Wound Regeneration.

Area of Science:

• Regenerative Medicine
• Biotechnology
• Wound Healing Research

Background:

• Chronic wounds (CWs) affect 1-2% of developed country populations, with 15% remaining unhealed after a year.
• Existing CW therapies (bandages, antibiotics, oxygen, grafts) have significant limitations like toxicity, cost, and inefficacy in diabetic patients.
• CWs severely impact patient quality of life and pose a substantial healthcare burden.

Purpose of the Study:

• To review the mechanisms of biological nanoparticles (BNPs) in promoting chronic wound healing.
• To explore the application of BNPs for targeted drug delivery in wound management.
• To evaluate innovative delivery platforms for BNPs and their clinical potential.

Main Methods:

• Review of current literature on biological nanoparticles (BNPs) and their role in wound healing.
• Analysis of the properties of extracellular vesicles (EVs) as a type of BNP.
• Examination of novel delivery systems like chitosan hydrogels and alginate films for BNPs.
• Assessment of clinical studies showcasing BNP efficacy, such as exosome-laden hydrogels for diabetic ulcers.

Main Results:

• BNPs, particularly EVs, exhibit biocompatibility, targeted delivery, and regenerative capabilities beneficial for CW healing.
• Innovative delivery platforms ensure sustained release and microenvironment responsiveness of BNPs.
• Clinical applications, like exosome hydrogels, show accelerated healing in complex cases such as diabetic ulcers.
• BNPs demonstrate potential to overcome limitations of conventional chronic wound therapies.

Conclusions:

• Biological nanoparticles (BNPs) represent a significant advancement in chronic wound management.
• BNPs offer a versatile platform for regenerative therapy and targeted drug delivery, improving patient outcomes.
• Further development of BNP-based therapies is crucial to address the challenges of chronic wound pathophysiology and healthcare costs.